Home
SWTX
SWTX News

Latest SpringWorks Therapeutics Inc. (SWTX) News on November 17, 2024

Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report

Simply Wall St.

2 days ago

Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report

SpringWorks Therapeutics Inc (SWTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

5 days ago

SpringWorks Therapeutics Inc (SWTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference

GlobeNewswire

5 days ago

SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference

SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study

TipRanks

5 days ago

SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study

SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

5 days ago

SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Earnings To Watch: SpringWorks Therapeutics Inc (SWTX) Reports Q3 2024 Result

GuruFocus.com

6 days ago

Earnings To Watch: SpringWorks Therapeutics Inc (SWTX) Reports Q3 2024 Result

SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

GlobeNewswire

6 days ago

SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

SpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical Oncology

GlobeNewswire

6 days ago

SpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical Oncology

SpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting

GlobeNewswire

10 days ago

SpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting

High Growth Tech Stocks To Watch In November 2024

Simply Wall St.

12 days ago

High Growth Tech Stocks To Watch In November 2024

SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

GlobeNewswire

12 days ago

SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

13 days ago

SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Good Position To Deliver On Growth Plans

SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

GlobeNewswire

a month ago

SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

SpringWorks Therapeutics Inc (SWTX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

a month ago

SpringWorks Therapeutics Inc (SWTX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

High Growth Tech Stocks in the United States for October 2024

Simply Wall St.

a month ago

High Growth Tech Stocks in the United States for October 2024

Even though SpringWorks Therapeutics (NASDAQ:SWTX) has lost US$229m market cap in last 7 days, shareholders are still up 49% over 5 years

Simply Wall St.

2 months ago

Even though SpringWorks Therapeutics (NASDAQ:SWTX) has lost US$229m market cap in last 7 days, shareholders are still up 49% over 5 years

SpringWorks Therapeutics Inc (SWTX) CEO Saqib Islam Sells 49,000 Shares

GuruFocus.com

2 months ago

SpringWorks Therapeutics Inc (SWTX) CEO Saqib Islam Sells 49,000 Shares

FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN

GlobeNewswire

3 months ago

FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN

High Growth Tech Stocks to Watch in August 2024

Simply Wall St.

3 months ago

High Growth Tech Stocks to Watch in August 2024

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates

Simply Wall St.

3 months ago

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Is Breakeven Near?

Simply Wall St.

3 months ago

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Is Breakeven Near?

SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

3 months ago

SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors

GlobeNewswire

4 months ago

SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors

SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

GlobeNewswire

4 months ago

SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

GlobeNewswire

5 months ago

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

Insider Sale: Director Julie Hambleton Sells Shares of SpringWorks Therapeutics Inc (SWTX)

GuruFocus.com

5 months ago

Insider Sale: Director Julie Hambleton Sells Shares of SpringWorks Therapeutics Inc (SWTX)

Insider Sale: COO Badreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics Inc (SWTX)

GuruFocus.com

5 months ago

Insider Sale: COO Badreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics Inc (SWTX)

Insider Sale: CEO Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX)

GuruFocus.com

5 months ago

Insider Sale: CEO Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX)

SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

5 months ago

SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

6 months ago

SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference

GlobeNewswire

6 months ago

SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference

Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

Simply Wall St.

6 months ago

Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

GuruFocus.com

6 months ago

SpringWorks Therapeutics Inc (SWTX) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

GlobeNewswire

7 months ago

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

7 months ago

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024

GlobeNewswire

7 months ago

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024

SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

GlobeNewswire

8 months ago

SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors

GlobeNewswire

9 months ago

SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors

SpringWorks Therapeutics Inc (SWTX) Reports Q4 and Full Year 2023 Financial Results

GuruFocus.com

9 months ago

SpringWorks Therapeutics Inc (SWTX) Reports Q4 and Full Year 2023 Financial Results

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

GlobeNewswire

9 months ago

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

SpringWorks Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

9 months ago

SpringWorks Therapeutics to Present at Upcoming Investor Conferences

SpringWorks Therapeutics Inc Insider Sells Company Shares

GuruFocus.com

9 months ago

SpringWorks Therapeutics Inc Insider Sells Company Shares

SpringWorks Therapeutics Inc Chief People Officer Daniel Pichl Sells 26,181 Shares

GuruFocus.com

9 months ago

SpringWorks Therapeutics Inc Chief People Officer Daniel Pichl Sells 26,181 Shares

Southwest Airlines (LUV) to Add More Routes to Las Vegas

Zacks

10 months ago

Southwest Airlines (LUV) to Add More Routes to Las Vegas

SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

10 months ago

SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Here's Why Urban Outfitters (URBN) Gained But Lagged the Market Today

Zacks

10 months ago

Here's Why Urban Outfitters (URBN) Gained But Lagged the Market Today

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

CNW Group

10 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

GlobeNewswire

10 months ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

Business Wire

10 months ago

Form 8.3 - DX (Group) plc

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

GlobeNewswire

10 months ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

Does Wingstop (NASDAQ:WING) Deserve A Spot On Your Watchlist?

Simply Wall St.

10 months ago

Does Wingstop (NASDAQ:WING) Deserve A Spot On Your Watchlist?

20 "Tech" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.

Motley Fool

10 months ago

20 "Tech" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.

4 Reasons to Buy Opendoor Stock

Motley Fool

10 months ago

4 Reasons to Buy Opendoor Stock

Better AI Buy: AMD vs. Symbotic Stock

Motley Fool

10 months ago

Better AI Buy: AMD vs. Symbotic Stock

Bundle and Save with Boost Mobile: Get the Summit Flip and One Year of Service for Only $129, Exclusively at Walmart

PR Newswire

10 months ago

Bundle and Save with Boost Mobile: Get the Summit Flip and One Year of Service for Only $129, Exclusively at Walmart

Parker-Hannifin (PH) to Post Q2 Earnings: Is a Beat in Store?

Zacks

10 months ago

Parker-Hannifin (PH) to Post Q2 Earnings: Is a Beat in Store?

Thomson Reuters StreetEvents

10 months ago

Q4 2023 CNX Resources Corp Earnings Call

Home Depot (HD) Rises Higher Than Market: Key Facts

Zacks

10 months ago

Home Depot (HD) Rises Higher Than Market: Key Facts

California Water Service Group Board of Directors Declares 316th Consecutive Quarterly Dividend and 57th Consecutive Annual Dividend Increase

GlobeNewswire

10 months ago

California Water Service Group Board of Directors Declares 316th Consecutive Quarterly Dividend and 57th Consecutive Annual Dividend Increase

Tesla Stock Slides After EV Maker Projects Slower Growth

The Wall Street Journal

10 months ago

Tesla Stock Slides After EV Maker Projects Slower Growth

CNX Resources (CNX) Q4 Earnings Beat Estimates, Revenues Lag

Zacks

10 months ago

CNX Resources (CNX) Q4 Earnings Beat Estimates, Revenues Lag

Janus Henderson Group plc (JHG) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

10 months ago

Janus Henderson Group plc (JHG) Expected to Beat Earnings Estimates: Should You Buy?

Valley National (VLY) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

10 months ago

Valley National (VLY) Reports Q4 Earnings: What Key Metrics Have to Say

IHG’s New Americas CEO: A Bet on Luxury and Moving at ‘China Speed’

Skift

10 months ago

IHG’s New Americas CEO: A Bet on Luxury and Moving at ‘China Speed’

Valley National (VLY) Misses Q4 Earnings and Revenue Estimates

Zacks

10 months ago

Valley National (VLY) Misses Q4 Earnings and Revenue Estimates

Chinese EV Maker Stocks Fall as Tesla Outlook Weighs

The Wall Street Journal

10 months ago

Chinese EV Maker Stocks Fall as Tesla Outlook Weighs

Analysts Estimate Hess (HES) to Report a Decline in Earnings: What to Look Out for

Zacks

10 months ago

Analysts Estimate Hess (HES) to Report a Decline in Earnings: What to Look Out for

Business Wire

10 months ago

Alarm.com to Announce 2023 Fourth Quarter and Full Year Results on February 22, 2024

It's Time to Worry About SolarEdge Stock

Motley Fool

10 months ago

It's Time to Worry About SolarEdge Stock

Why Alarm.com (ALRM) is Poised to Beat Earnings Estimates Again

Zacks

10 months ago

Why Alarm.com (ALRM) is Poised to Beat Earnings Estimates Again

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now

Zacks

10 months ago

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now

Estimating The Intrinsic Value Of Southwest Gas Holdings, Inc. (NYSE:SWX)

Simply Wall St.

10 months ago

Estimating The Intrinsic Value Of Southwest Gas Holdings, Inc. (NYSE:SWX)

These Stocks Are Moving the Most Today: Archer Daniels, NuStar Energy, Gilead, Spirit Airlines, Western Digital, and More

Barrons.com

10 months ago

These Stocks Are Moving the Most Today: Archer Daniels, NuStar Energy, Gilead, Spirit Airlines, Western Digital, and More

With EPS Growth And More, Asbury Automotive Group (NYSE:ABG) Makes An Interesting Case

Simply Wall St.

10 months ago

With EPS Growth And More, Asbury Automotive Group (NYSE:ABG) Makes An Interesting Case

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

These 3 Buy-Rated Stocks Have Been Red-Hot

Zacks

10 months ago

These 3 Buy-Rated Stocks Have Been Red-Hot

Halozyme Announces argenx Received Approval in Japan for VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Co-Formulated with ENHANZE® for Generalized Myasthenia Gravis

PR Newswire

10 months ago

Halozyme Announces argenx Received Approval in Japan for VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Co-Formulated with ENHANZE® for Generalized Myasthenia Gravis

Investing.com

10 months ago

Midday movers: Apple climbs, Humana slumps, and more

WNS Announces Fiscal 2024 Third Quarter Earnings, Revises Full Year Guidance

Business Wire

10 months ago

WNS Announces Fiscal 2024 Third Quarter Earnings, Revises Full Year Guidance

Why You Should Retain Public Storage (PSA) Stock for Now

Zacks

10 months ago

Why You Should Retain Public Storage (PSA) Stock for Now

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)

StockStory

10 months ago

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)

Here's Why Hold Strategy is Apt for ExlService (EXLS) Stock Now

Zacks

10 months ago

Here's Why Hold Strategy is Apt for ExlService (EXLS) Stock Now

Reasons to Add Leonardo DRS (DRS) to Your Portfolio Now

Zacks

10 months ago

Reasons to Add Leonardo DRS (DRS) to Your Portfolio Now

Wall Street Analysts Believe MoonLake Immunotherapeutics (MLTX) Could Rally 26.97%: Here's is How to Trade

Zacks

10 months ago

Wall Street Analysts Believe MoonLake Immunotherapeutics (MLTX) Could Rally 26.97%: Here's is How to Trade

Do Main Street Capital's (NYSE:MAIN) Earnings Warrant Your Attention?

Simply Wall St.

10 months ago

Do Main Street Capital's (NYSE:MAIN) Earnings Warrant Your Attention?

FormFactor to Announce Fourth Quarter 2023 Financial Results on February 7th

GlobeNewswire

10 months ago

FormFactor to Announce Fourth Quarter 2023 Financial Results on February 7th

Leonardo DRS Awarded Contracts Valued at Over $3 Billion for U.S. Navy’s Columbia-Class Submarine Program

Business Wire

10 months ago

Leonardo DRS Awarded Contracts Valued at Over $3 Billion for U.S. Navy’s Columbia-Class Submarine Program

Ashland announces organization changes to finance and strategy, M&A and portfolio teams

GlobeNewswire

10 months ago

Ashland announces organization changes to finance and strategy, M&A and portfolio teams

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

SouthState Corporation to Announce Quarterly Earnings Results on Thursday, January 25, 2024

PR Newswire

10 months ago

SouthState Corporation to Announce Quarterly Earnings Results on Thursday, January 25, 2024

Virtual Reality Ventures: 3 Stocks Pioneering Immersive Technology

InvestorPlace

10 months ago

Virtual Reality Ventures: 3 Stocks Pioneering Immersive Technology

Insiders have been selling Asana, Inc. (NYSE:ASAN) recently yet still hold a significant stake; 8.7% drop last week not ideal

Simply Wall St.

10 months ago

Insiders have been selling Asana, Inc. (NYSE:ASAN) recently yet still hold a significant stake; 8.7% drop last week not ideal

Kirby Corporation Announces Date for 2023 Fourth Quarter Earnings Release and Earnings Webcast

GlobeNewswire

10 months ago

Kirby Corporation Announces Date for 2023 Fourth Quarter Earnings Release and Earnings Webcast

How TMSL Finds Opportunities in Small Cap Stocks

ETF Trends

a year ago

How TMSL Finds Opportunities in Small Cap Stocks

SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Brookfield Infrastructure Announces Results of Reclassification of Its Series 11 Preferred Units

GlobeNewswire

a year ago

Brookfield Infrastructure Announces Results of Reclassification of Its Series 11 Preferred Units

Is Atmos Energy (ATO) Stock Outpacing Its Utilities Peers This Year?

Zacks

a year ago

Is Atmos Energy (ATO) Stock Outpacing Its Utilities Peers This Year?

California Resources Corporation Announces January Investor Conference Participation

Business Wire

a year ago

California Resources Corporation Announces January Investor Conference Participation

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

Business Wire

a year ago

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

Cadence Bank (CADE) Rises 5.9% on New Share Buyback Program

Zacks

a year ago

Cadence Bank (CADE) Rises 5.9% on New Share Buyback Program

Share on Social Networks: